HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung cancer and residency--a case-referent study on the possible impact of of exposure to radon and its daughters in dwellings.

Abstract
In view of the well-known urban-rural difference in lung cancer rates, remaining also after standardization for smoking, it is suggested that low levels of radon and its daughters in dwellings might be of etiologic importance to this disease. To test this hypothesis, a case-referent (case-control) study was undertaken in a rural area; it considered residency in wooden houses (assumed to be associated with low-level exposure to radon and its daughters), "mixed type" houses (medium exposure) and stone houses (high-level exposure) among cases of lung cancer and referents (controls). The results indicate an increased risk of lung cancer among residents in "mixed type" and stone houses. Additional studies are highly desirable to confirm or refute these findings, which, if valid, mean increasing lung cancer hazards caused by a decrease in ventilation in future energy saving unless special measures are undertaken to reduce radon daughters in dwellings.
AuthorsO Axelson, C Edling, H Kling
JournalScandinavian journal of work, environment & health (Scand J Work Environ Health) Vol. 5 Issue 1 Pg. 10-5 (Mar 1979) ISSN: 0355-3140 [Print] Finland
PMID441704 (Publication Type: Journal Article)
Chemical References
  • Air Pollutants
  • Air Pollutants, Radioactive
  • Radon
Topics
  • Adult
  • Aged
  • Air Pollutants (adverse effects)
  • Air Pollutants, Radioactive (adverse effects)
  • Environmental Exposure
  • Female
  • Humans
  • Lung Neoplasms (epidemiology, etiology)
  • Male
  • Middle Aged
  • Neoplasms, Radiation-Induced (epidemiology)
  • Radon (adverse effects)
  • Residence Characteristics
  • Smoking (complications)
  • Sweden
  • Urban Population

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: